An expert discusses how gene therapy represents a breakthrough treatment approach for BCG-unresponsive patients, offering ...

An expert discusses how patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) now have several ...

A new Business Group on Health survey finds that nearly a quarter of all employer healthcare spending (24%) went to pharmacy ...

We’ll be back on Monday morning with more fresh content!

In this final video of a three-part video series, Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and a ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In this second part of a three-part of a video series, Kasey Raetz, Pharm.D., a PBMI Innovator, told MHE about leading the ...

Sexual and gender minority individuals still face insurance denials and cost-sharing barriers when accessing pre-exposure ...

A new study finds Medicare beneficiaries are facing higher deductibles and cost-sharing requirements following changes ...

Developed by Ionis Pharmaceuticals, Dawnzera is the first RNA-targeted medicine approved for HAE, designed to target plasma ...

The next step for the Rise For Health study researchers is to study the health benefits of frequent standing in older men and ...

Prefilled syringes of Imuldosa now have the lowest wholesaler acquisition cost among all branded ustekinumab biosimilars, ...